P53 protein expression and polymorphism of GSTT1 and GSTM1 genes in central lung cancer

N. V. Sevostyanova, A. I. Dmitrieva, V. V. Novitskiy, E. Choinzonov, S. Kolomiets (Tomsk, Russian Federation)

Source: Annual Congress 2006 - Pathogenic aspects of lung injury, destruction and repair
Session: Pathogenic aspects of lung injury, destruction and repair
Session type: Thematic Poster Session
Number: 1159
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. V. Sevostyanova, A. I. Dmitrieva, V. V. Novitskiy, E. Choinzonov, S. Kolomiets (Tomsk, Russian Federation). P53 protein expression and polymorphism of GSTT1 and GSTM1 genes in central lung cancer. Eur Respir J 2006; 28: Suppl. 50, 1159

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Polymorphism of GSTT1 and GSTM1 genes in lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006

The influence of the polymorphism at codon 72 of exon 4 of the P53 gene and GSTM1 and GSTT1 null in lung cancer risk in a Brazilian population
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006

TP53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) development
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006


The effect of polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) on lung cancer outcome
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005


Genetic polymorphisms CYP1A1 m1, GSTM1, GSTT1 null and lung cancer susceptibility in a Brazilian population
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006

Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC)
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006

Association of GSTT1, GSTM1 and CYP1A1 MSP1 gene polymorphism with lung cancer patients in north Indian population
Source: Annual Congress 2010 - Epidemiology of lung cancer
Year: 2010

Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 136s
Year: 2004

CYP1A1, GSTT1 and GSTM1 polymorphism in relation to lung cancer in eastern Poland
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

The role of GSTT1 and GSTM1 gene polymorphisms in bronchial asthma
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018


Metabolic gene polymorphisms (CYP1A1, EPHX1, GSTM1 and GSTP1) associations with the severity of cystic fibfosis airway disease
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

The influence of polymorphism of GSTT1 ,GSTM1, ACE genes on the development of BA in children
Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis
Year: 2009

The leucocyte telomere length, GSTM1 and GSTT1 null genotypes and the risk of COPD
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Analysis of association between the GSTT1 and GSTM1 genes polymorphism and asthma-associated traits (AAT)
Source: Eur Respir J 2003; 22: Suppl. 45, 581s
Year: 2003

Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008



Genetic polymorphism of epoxide hydrolase and GSTM1 in lung cancer susceptibility
Source: Eur Respir J 2002; 20: Suppl. 38, 229s
Year: 2002

Influence of common p53 and XRCC1 variant alleles on risk of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006

Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011